Fact CheckerSign in

NCT01737242Active, not recruiting

UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

The UKGPCS was set up to find genetic alterations which occur in patients who have prostate cancer. A man's risk of developing prostate cancer increases if he has a first-degree relative (father or brother) who was diagnosed with prostate cancer at a young age. This is why we are looking for men who are affected at a young age or who have a family history of prostate cancer, since it is more probable that these prostate cancers are due to an inherited genetic cause rather than an environmental cause. We also ask all men who come to the Royal Marsden Hospital to be treated for prostate cancer if they would like to take part in the study so that we can also look to see if we find genetic alterations in older men, and those who do not have a family history of prostate cancer.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
23826 (actual)
First submitted
27 Nov 2012
Start date
Jan 1993
Primary completion date
Nov 2023
Lead sponsor
Institute of Cancer Research, United Kingdom
NCT number
NCT01737242

What you commit to

  • Study type: Observational
  • Participants enrolled: 23826
  • From Jan 1993 to the primary completion date, Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Man with PrCa who is too ill to take part

Who the study is looking for

  • Man with PrCa at any age at diagnosis at Royal Marsden NHS Foundation Trust
  • Those outside the Royal Marsden NHS Foundation Trust with
  • PrCa at or below 60 years at diagnosis
  • PrCa in first-degree related pairs where one is ≤ 65 years at diagnosis
  • PrCa at any age in a cluster with 3 or more cases
  • Those able to understand the information sheet and give informed consent (language line is available for those who wish to have translation)
  • Any unaffected relatives of men who are already taking part in the study

Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institute of Cancer Research and Royal Marsden Hospital
Coordinator of this site? Confirm its status
SuttonUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.